Bukwang Pharmaceutical Co., Ltd. (KRX:003000)

Bukwang Pharmaceutical Statistics

Total Valuation

KRX:003000 has a market cap or net worth of KRW 373.94 billion. The enterprise value is 315.02 billion.

Market Cap	373.94B
Enterprise Value	315.02B

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	n/a

Share Statistics

KRX:003000 has 98.66 million shares outstanding. The number of shares has increased by 0.19% in one year.

Current Share Class	98.66M
Shares Outstanding	98.66M
Shares Change (YoY)	+0.19%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	14.01%
Owned by Institutions (%)	2.89%
Float	67.95M

Valuation Ratios

The trailing PE ratio is 31.18.

PE Ratio	31.18
Forward PE	n/a
PS Ratio	2.09
PB Ratio	1.49
P/TBV Ratio	1.55
P/FCF Ratio	11.40
P/OCF Ratio	9.87
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.71, with an EV/FCF ratio of 9.60.

EV / Earnings	37.68
EV / Sales	1.76
EV / EBITDA	21.71
EV / EBIT	32.16
EV / FCF	9.60

Financial Position

The company has a current ratio of 5.77, with a Debt / Equity ratio of 0.32.

Current Ratio	5.77
Quick Ratio	4.30
Debt / Equity	0.32
Debt / EBITDA	5.39
Debt / FCF	2.45
Interest Coverage	1.57

Financial Efficiency

Return on equity (ROE) is 3.41% and return on invested capital (ROIC) is 1.99%.

Return on Equity (ROE)	3.41%
Return on Assets (ROA)	1.73%
Return on Invested Capital (ROIC)	1.99%
Return on Capital Employed (ROCE)	2.94%
Revenue Per Employee	291.32M
Profits Per Employee	13.59M
Employee Count	615
Asset Turnover	0.49
Inventory Turnover	1.98

Taxes

Income Tax	-6.75B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.90% in the last 52 weeks. The beta is 0.75, so KRX:003000's price volatility has been lower than the market average.

Beta (5Y)	0.75
52-Week Price Change	-24.90%
50-Day Moving Average	3,446.90
200-Day Moving Average	4,097.96
Relative Strength Index (RSI)	72.39
Average Volume (20 Days)	500,246

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:003000 had revenue of KRW 179.16 billion and earned 8.36 billion in profits. Earnings per share was 121.56.

Revenue	179.16B
Gross Profit	81.00B
Operating Income	10.16B
Pretax Income	1.43B
Net Income	8.36B
EBITDA	14.88B
EBIT	10.16B
Earnings Per Share (EPS)	121.56

Balance Sheet

The company has 139.59 billion in cash and 80.24 billion in debt, giving a net cash position of 59.35 billion or 601.49 per share.

Cash & Cash Equivalents	139.59B
Total Debt	80.24B
Net Cash	59.35B
Net Cash Per Share	601.49
Equity (Book Value)	250.51B
Book Value Per Share	3,653.27
Working Capital	179.32B

Cash Flow

In the last 12 months, operating cash flow was 37.87 billion and capital expenditures -5.06 billion, giving a free cash flow of 32.81 billion.

Operating Cash Flow	37.87B
Capital Expenditures	-5.06B
Free Cash Flow	32.81B
FCF Per Share	332.55

Margins

Gross margin is 45.21%, with operating and profit margins of 5.67% and 4.67%.

Gross Margin	45.21%
Operating Margin	5.67%
Pretax Margin	0.80%
Profit Margin	4.67%
EBITDA Margin	8.30%
EBIT Margin	5.67%
FCF Margin	18.31%

Dividends & Yields

KRX:003000 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.19%
Shareholder Yield	n/a
Earnings Yield	2.24%
FCF Yield	8.77%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on December 29, 2020. It was a forward split with a ratio of 1.1.

Last Split Date	Dec 29, 2020
Split Type	Forward
Split Ratio	1.1

Scores

KRX:003000 has an Altman Z-Score of 3.2 and a Piotroski F-Score of 6.

Altman Z-Score	3.2
Piotroski F-Score	6